There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

A nickel's worth of free advice to the competition could come at the expense of your bottom line.

Shipping with the Enemy?

In Part I of a three-part article, the authors discuss what constitutes an impurity and the potential sources of impurities in APIs and finished drug products.

Evaluating Impurities in Drugs (Part I of III)

Where is the variability coming from and what have we done to minimize it?

Reducing Common Cause Variation

The Asian nation is strategizing to take the lead over its regional competitors in pharmaceutical exports.

Report from India

In the Spotlight February 2012

Technology may expedite operations, but the absence of the human element could cost dearly.

All Systems Slow

Sean Milmo is a freelance writer based in Essex, UK.

The European Union market takes steps toward continuous processing and modular facilities.

Report from Europe

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the December 2011 edition from Banner Engineering and Eriez.

December 2011 Editor's Picks: Products from Banner Engineering and Eriez

Risk assessment is not a new concept to the pharmaceutical industry, but lately the phrase has become a mantra. A systemic, science-based way to manage risk is becoming essential to meeting the spirit and letter of FDA requirements.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes